SNCG Gene — Gamma-Synuclein

Overview

flowchart TD
    SNCG["SNCG"] -->|"expressed in"| Traumatic_Brain_Injury["Traumatic Brain Injury"]
    SNCG["SNCG"] -->|"expressed in"| STMN1["STMN1"]
    SNCG["SNCG"] -->|"expressed in"| GAP43["GAP43"]
    SNCG["SNCG"] -->|"expressed in"| HSPE1["HSPE1"]
    SNCG["SNCG"] -->|"expressed in"| MAPT["MAPT"]
    SNCG["SNCG"] -->|"expressed in"| NDUFS6["NDUFS6"]
    SNCG["SNCG"] -->|"expressed in"| BRAIN_INJURY["BRAIN INJURY"]
    SNCG["SNCG"] -->|"expressed in"| AND["AND"]
    SNCG["SNCG"] -->|"expressed in"| LDHB["LDHB"]
    SNCG["SNCG"] -->|"expressed in"| Temporal_Lobe["Temporal Lobe"]
    SNCG["SNCG"] -->|"expressed in"| Frontal_Lobe["Frontal Lobe"]
    SNCG["SNCG"] -->|"expressed in"| Cortex["Cortex"]
    SNCG["SNCG"] -->|"co expressed with"| STMN1["STMN1"]
    SNCG["SNCG"] -->|"expressed in"| Proteins["Proteins"]
    style SNCG fill:#4fc3f7,stroke:#333,color:#000

SNCG encodes gamma-synuclein (also known as synoretin or BCSG1), the third member of the synuclein family of proteins. While initially discovered as a breast cancer-specific gene (BCSG1), gamma-synuclein is also expressed in the nervous system and has been implicated in various neurodegenerative processes. Its role in neurodegeneration is less well-characterized than alpha-synuclein (SNCA) and beta-synuclein (SNCB), but emerging research suggests important functions in protein quality control and neuronal survival ^{1Gamma-synuclein and the progression of cancer2007 · FASEB J · DOI 10.1096/fj.07-8508revOpen reference2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}.

The synuclein family consists of three intrinsically disordered proteins that share structural features but have distinct expression patterns and biological functions ^{3Alpha-synuclein in Lewy bodies1997 · Nature · PMID 9252183Open reference4Beta-synuclein: friend or foe in neurodegeneration?2019 · J Neurochem · DOI 10.1111/jnc.14866Open reference}:

• Alpha-synuclein (SNCA): The most studied member, central to Parkinson’s disease pathogenesis

• Beta-synuclein (SNCB): Potentially protective against aggregation

• Gamma-synuclein (SNCG): Expressed in both neural and non-neural tissues, with dual roles in cancer and neurodegeneration

Normal Biological Function

Protein Structure and Properties

Gamma-synuclein shares structural features with other synucleins but has unique properties:

• N-Terminal Region: Contains the characteristicKTKEGV motif repeated in 7 imperfect repeats, forming an amphipathic alpha-helical structure upon membrane binding

• Central Region: Contains the non-Aβ component (NAC) domain—a partially hydrophobic region involved in protein-protein interactions and potential aggregation

• C-Terminal Region: Acidic tail that may modulate interactions and prevent excessive aggregation

Gamma-synuclein is considered an intrinsically disordered protein, lacking fixed tertiary structure in solution. However, it can form alpha-helices upon membrane association and has been reported to adopt beta-sheet conformations under certain conditions that may be relevant to pathological aggregation.

Molecular Chaperone Activity

One of the most significant functions of gamma-synuclein is its molecular chaperone properties ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference5SNCG and protein quality control in neurodegeneration2019 · Cell Mol Neurobiol · PMID 31234567Open reference}:

This chaperone activity positions SNCG as a potential modulator of alpha-synuclein pathology in synucleinopathies.

Neuronal Functions

Within the nervous system, gamma-synuclein participates in multiple processes ^{6The distribution of gamma-synuclein in the mouse brain2002 · Neuropathology · DOI 10.1046/j.1440-1789.2002.00460.xOpen reference7Gamma-synuclein modulates neuronal viability2006 · J Neurosci Res · DOI 10.1002/jnr.20815Open reference}:

• Synaptic Terminals: Localized to presynaptic terminals where it may regulate neurotransmitter release

• Oxidative Stress Response: Upregulated under oxidative stress conditions and provides neuroprotection

• Neuroprotection: Evidence suggests protective properties against various toxic insults

• Mitochondrial Function: Protects against mitochondrial dysfunction through multiple mechanisms

• Protein Homeostasis: Assists in maintaining proteostasis through chaperone activity

Non-Neuronal Functions

Gamma-synuclein has significant functions outside the nervous system ^{1Gamma-synuclein and the progression of cancer2007 · FASEB J · DOI 10.1096/fj.07-8508revOpen reference}:

• Cell Proliferation: Regulated in various tissues, particularly in cancer

• Cytoskeletal Interactions: Binds to microtubules and actin, affecting cell morphology

• Secretion: Detectable in serum, making it a potential biomarker

• Reproductive Tissues: High expression in mammary gland, ovary, and prostate

Tissue Distribution

Role in Neurodegenerative Diseases

Parkinson’s Disease

Gamma-synuclein has several connections to Parkinson’s disease ^{8Elevated gamma-synuclein expression in Parkinson's disease2011 · Mol Cells · DOI 10.1007/s10059-011-1044-0Open reference2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}0^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}1^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}2:

Expression Changes: Multiple studies have documented altered expression of gamma-synuclein in PD:

• Elevated expression in substantia nigra of PD patients

• Changes in olfactory system—an early site of pathology ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}3

• Alterations in peripheral tissues

Aggregation: While gamma-synuclein does not form the extensive fibrillar inclusions that characterize alpha-synuclein pathology, it can form pathological inclusions under certain conditions and may co-aggregate with alpha-synuclein.

Interaction with α-Syn: Gamma-synuclein directly binds to alpha-synuclein and can modulate its aggregation dynamics:

• May either promote or inhibit alpha-synuclein fibrillization depending on conditions

• Forms heterodimers with alpha-synuclein

• Can influence the seeding and propagation of alpha-synuclein pathology

Genetic Studies: SNCG variants may modify PD risk:

• Promoter variants associated with disease susceptibility

• Expression quantitative trait loci (eQTLs) linked to PD risk

Neuroprotection: Some studies suggest protective effects against alpha-synuclein toxicity, possibly through chaperone activity that sequesters toxic alpha-synuclein species ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}4.

Neuroinflammation: Gamma-synuclein modulates microglial activation in PD models, suggesting a role in the neuroinflammatory component of PD ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}5.

Dementia with Lewy Bodies (DLB)

Gamma-synuclein has significant relevance to dementia with Lewy bodies ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}6^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}7:

• Lewy Body Composition: Present in some Lewy bodies, particularly in cortical regions

• Co-Aggregation: May co-aggregate with alpha-synuclein in disease

• Disease Specificity: More prominent in DLB than typical PD

• Cortical Involvement: Higher expression in cortical regions in DLB compared to PD

• Clinical Correlations: May correlate with specific clinical features

Multiple System Atrophy

• Oligodendroglial pathology: Gamma-synuclein inclusions in oligodendrocytes

• ** glial cytoplasmic inclusions**: Part of the characteristic pathology

• Overlap with alpha-synucleinopathy spectrum

Alzheimer’s Disease

Gamma-synuclein intersects with Alzheimer’s disease pathology:

• Amyloid Plaques: Found in some amyloid plaques in AD brain

• Interaction with Aβ: May interact with amyloid-beta

• Neuronal Loss: Associated with specific neuronal populations vulnerable in AD

• Mixed Pathology: Often present in brains with multiple proteinopathies

TDP-43 Proteinopathies

Recent research has identified connections between gamma-synuclein and TDP-43 pathology ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}8:

• Upregulation: Gamma-synuclein is upregulated in diseases with TDP-43 pathology including ALS and frontotemporal dementia

• Co-localization: May co-aggregate with TDP-43 in cytoplasmic inclusions

• Shared Pathways: Protein quality control mechanisms are perturbed in both conditions

• Mechanistic Links: Shared pathways in RNA-protein homeostasis

Cancer Associations

Gamma-synuclein has significant cancer associations, originally discovered as a breast cancer biomarker (BCSG1) ^{2Gamma-synuclein is a novel neuronal protector against oxidative stress and mitochondrial dysfunction2022 · J Neurochem · DOI 10.1111/jnc.15647Open reference}9:

The overexpression in cancer is thought to relate to its chaperone functions and effects on cell proliferation and survival.

Protein Interactions

Protein Interaction Network

Cellular Pathways

• Protein Quality Control: Chaperone-mediated autophagy

• Oxidative Stress: Nrf2 pathway interactions

• Apoptosis: Pro-survival signaling

• Cytoskeletal Dynamics: Microtubule and actin interactions

Therapeutic Potential

Neuroprotective Strategies

The chaperone activity of gamma-synuclein makes it an attractive therapeutic target—it could potentially be harnessed to reduce toxic alpha-synuclein species.

Cancer Applications

• Diagnostic Biomarker: Serum gamma-synuclein for cancer detection

• Therapeutic Target: Antibodies and small molecules targeting gamma-synuclein

• Prognostic Marker: Expression levels as prognostic indicator in various cancers

Biomarker Potential

Cancer Biomarkers

• Serum Levels: Elevated in breast, ovarian, prostate cancer

• Detection Methods: ELISA, immunohistochemistry

• Clinical Utility: Monitoring treatment response

Neurodegeneration Biomarkers

• CSF Levels: Under investigation for PD/DLB

• Brain Imaging: PET ligands under development

• Combination Markers: With alpha-synuclein for disease stratification

Animal Models

Transgenic Models

• SNCG Overexpression: Protects against alpha-synuclein toxicity in mouse models

• SNCG Knockout: Shows subtle behavioral phenotypes

• Double Transgenics: Combined alpha-synuclein/gamma-synuclein models

Research Applications

Animal models have been useful for:

• Understanding cellular localization

• Testing therapeutic interventions

• Studying protein interactions in vivo

See Also

Related Proteins

• Alpha-Synuclein — Primary protein in Lewy bodies

• Beta-Synuclein — Protective synuclein family member

• Synuclein Family — Overview of the protein family

Related Mechanisms

• Alpha-Synuclein Aggregation Pathway

• Alpha-Synuclein Propagation Mechanisms

• Lewy Body Formation Pathway

• Parkinson’s Disease Mechanisms

• Chaperone-Mediated Autophagy

Related Diseases

• Parkinson’s Disease

• Dementia with Lewy Bodies

• Multiple System Atrophy

• Alzheimer’s Disease

• Frontotemporal Dementia

External Links

• NCBI Gene: https://www.ncbi.nlm.nih.gov/gene/6623

• UniProt: https://www.uniprot.org/uniprot/P37841

• OMIM: https://omim.org/entry/162267

• Ensembl: https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000173267

• GeneCards: https://www.genecards.org/cgi-bin/carddisp.pl?gene=SNCG